Todd P. Branning - Net Worth and Insider Trading
Todd P. Branning Net Worth
The estimated net worth of Todd P. Branning is at least $567 dollars as of 2024-11-13. Todd P. Branning is the CFO of NeuBase Therapeutics Inc and owns about 1,500 shares of NeuBase Therapeutics Inc (NBSE) stock worth over $567. Details can be seen in Todd P. Branning's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Todd P. Branning has not made any transactions after 2022-03-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Todd P. Branning
Todd P. Branning Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Todd P. Branning owns 3 companies in total, including Phathom Pharmaceuticals Inc (PHAT) , Amneal Pharmaceuticals Inc (AMRX) , and NeuBase Therapeutics Inc (NBSE) .
Click here to see the complete history of Todd P. Branning’s form 4 insider trades.
Insider Ownership Summary of Todd P. Branning
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PHAT | Phathom Pharmaceuticals Inc | 2020-07-13 | Chief Financial Officer |
| AMRX | Amneal Pharmaceuticals Inc | 2020-02-27 | SVP and CFO |
| NBSE | NeuBase Therapeutics Inc | 2022-03-18 | Chief Financial Officer |
Todd P. Branning Latest Holdings Summary
Todd P. Branning currently owns a total of 1 stock. Todd P. Branning owns 1,500 shares of NeuBase Therapeutics Inc (NBSE) as of March 18, 2022, with a value of $567.
Latest Holdings of Todd P. Branning
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NBSE | NeuBase Therapeutics Inc | 2022-03-18 | 1,500 | 0.38 | 567 |
Holding Weightings of Todd P. Branning
Todd P. Branning Form 4 Trading Tracker
According to the SEC Form 4 filings, Todd P. Branning has made a total of 2 transactions in NeuBase Therapeutics Inc (NBSE) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in NeuBase Therapeutics Inc is the acquisition of 500 shares on March 18, 2022, which cost Todd P. Branning around $18,100.
Insider Trading History of Todd P. Branning
- 1
Todd P. Branning Trading Performance
GuruFocus tracks the stock performance after each of Todd P. Branning's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Todd P. Branning is -52.79%. GuruFocus also compares Todd P. Branning's trading performance to market benchmark return within the same time period. The performance of stocks bought by Todd P. Branning within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Todd P. Branning's insider trading performs compared to the benchmark.
Performance of Todd P. Branning
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -11.95 | | | | | |
| Relative Return to S&P 500(%) | -10.94 | | | | | |
Todd P. Branning Ownership Network
Ownership Network List of Todd P. Branning
Ownership Network Relation of Todd P. Branning
Todd P. Branning Owned Company Details
What does Phathom Pharmaceuticals Inc do?
Who are the key executives at Phathom Pharmaceuticals Inc?
Todd P. Branning is the Chief Financial Officer of Phathom Pharmaceuticals Inc. Other key executives at Phathom Pharmaceuticals Inc include CFO and CBO Molly Henderson , Chief Operating Officer Azmi Nabulsi , and 10 percent owner Takeda Pharmaceutical Co Ltd .
Phathom Pharmaceuticals Inc (PHAT) Insider Trades Summary
Over the past 18 months, Todd P. Branning made no insider transaction in Phathom Pharmaceuticals Inc (PHAT). Other recent insider transactions involving Phathom Pharmaceuticals Inc (PHAT) include a net sale of 32,756 shares made by Molly Henderson , a net sale of 50,699 shares made by Terrie Curran , and a net sale of 3,703,703 shares made by Takeda Pharmaceutical Co Ltd .
In summary, during the past 3 months, insiders sold 0 shares of Phathom Pharmaceuticals Inc (PHAT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,798,059 shares of Phathom Pharmaceuticals Inc (PHAT) were sold and 7,500 shares were bought by its insiders, resulting in a net sale of 3,790,559 shares.
Phathom Pharmaceuticals Inc (PHAT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Phathom Pharmaceuticals Inc Insider Transactions
Todd P. Branning Mailing Address
Above is the net worth, insider trading, and ownership report for Todd P. Branning. You might contact Todd P. Branning via mailing address: C/o Amneal Pharmaceuticlas, Inc., 400 Crossing Boulevard, Bridgewater Nj 08807.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
